This company listing is no longer active
BBS-Bioactive Bone Substitutes Oyj Past Earnings Performance
Past criteria checks 0/6
Key information
-8.0%
Earnings growth rate
1.6%
EPS growth rate
| Biotechs Industry Growth | 14.8% |
| Revenue growth rate | n/a |
| Return on equity | -76.3% |
| Net Margin | n/a |
| Next Earnings Update | 25 Aug 2022 |
Recent past performance updates
No updates
Recent updates
No updates
Revenue & Expenses Breakdown
How BBS-Bioactive Bone Substitutes Oyj makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 21 | 0 | -3 | 1 | 0 |
| 30 Sep 21 | 0 | -3 | 1 | 0 |
| 30 Jun 21 | 0 | -3 | 1 | 0 |
| 31 Mar 21 | 0 | -3 | 1 | 0 |
| 31 Dec 20 | 0 | -3 | 1 | 0 |
| 30 Sep 20 | 0 | -2 | 1 | 0 |
| 30 Jun 20 | 0 | -2 | 1 | 0 |
| 31 Mar 20 | 0 | -2 | 1 | 0 |
| 31 Dec 19 | 0 | -2 | 1 | 0 |
| 30 Sep 19 | 0 | -2 | 1 | 0 |
| 30 Jun 19 | 0 | -2 | 1 | 0 |
| 31 Mar 19 | 0 | -1 | 1 | 0 |
| 31 Dec 18 | 0 | 0 | 1 | 0 |
| 30 Sep 18 | 0 | -1 | 1 | 0 |
| 30 Jun 18 | 0 | -3 | 1 | 0 |
| 31 Mar 18 | 0 | -4 | 1 | 0 |
| 31 Dec 17 | 0 | -4 | 1 | 0 |
| 31 Dec 16 | 0 | -1 | 0 | 0 |
Quality Earnings: BONEHN0122 is currently unprofitable.
Growing Profit Margin: BONEHN0122 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BONEHN0122 is unprofitable, and losses have increased over the past 5 years at a rate of 8% per year.
Accelerating Growth: Unable to compare BONEHN0122's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BONEHN0122 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-6.2%).
Return on Equity
High ROE: BONEHN0122 has a negative Return on Equity (-76.25%), as it is currently unprofitable.